跳至主要内容
临床试验/EUCTR2004-000592-33-SE
EUCTR2004-000592-33-SE进行中(未招募)不适用

Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF Study

Gentium S.p.A0 个研究点目标入组 270 人开始时间: 2006年1月5日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients < 18 years who have myeloablative conditioning and at least one of the following risk factors:
  • Children having a second myeloablative stem cell transplant
  • Allogeneic stem cell transplants for leukaemia >2 relapses
  • Liver disease
  • History of treatment with gemtuzumab ozogamicin (Mylotarg)
  • Conditioning with busulfan and melphalan
  • Osteopetrosis
  • Macrophage activating syndromes
  • Adrenoleukodystrophy
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Those who do not fulfill the inclusion criteria.
  • Patients who are pregnant.

研究者

发起方
Gentium S.p.A

相似试验

进行中(未招募)
不适用
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantation
EUCTR2004-000592-33-IEGentium S.p.A290
进行中(未招募)
1 期
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1 Level: LLT Classification code 10047217 Term: Venoocclusive syndrome of the liverMedDRA version: 9.1 Level: LLT Classification code 10047207 Term: Veno-occlusive liver damage
EUCTR2004-000592-33-GBGentium S.p.A270
进行中(未招募)
不适用
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1Level: LLTClassification code 10047217Term: Venoocclusive syndrome of the liverMedDRA version: 9.1Level: LLTClassification code 10047207Term: Veno-occlusive liver damage
EUCTR2004-000592-33-CZGentium S.p.A270
进行中(未招募)
不适用
Prospective study of the incidence and outcome of Veno-occlusive disease (VOD)with the prophylactic use of Defibrotide (DF, Gentium, Italy) in pediatric stem cell transplantatioPrevention of hepatic veno-occlusive disease in pediatric patients at high risk of VODMedDRA version: 14.1Level: PTClassification code 10047216Term: Venoocclusive liver diseaseSystem Organ Class: 10019805 - Hepatobiliary disorders
EUCTR2004-000592-33-ITGENTIUM360
尚未招募
Unknown
Incidence of catheter colonization in Regional Anaesthesia.
CTRI/2024/05/067327Fluid research Grant Christian Medical College Vellore